Novartis Foundation

Last updated
Novartis Foundation
FormerlyBasel Foundation for Developing Countries (founded 1961),

Ciba-Geigy Foundation for Cooperation with Developing

Countries (as of 1979), Novartis Foundation for Sustainable Development (as of 1996)

Contents

Company type Foundation
Industry Pharmaceutical Industry
FoundedJune 1, 1979
Headquarters Basel, Switzerland
Key people
Ann Aerts, MD (Head)
Website www.novartisfoundation.org

The Novartis Foundation (formerly known as the Novartis Foundation for Sustainable Development) is a non-profit organization and part of the corporate responsibility portfolio of Novartis in Basel, Switzerland. The foundation conducts projects to improve health, mostly in sub-Saharan Africa and in south-east Asia.

History

The Novartis Foundation has been one of the leading organizations in the private sector for international development for the last 35 years. The humanitarian engagement of the Novartis Foundation goes back to the 1960s, when the Basel-based companies Ciba, Geigy, Sandoz, Durand & Huguenin, Hoffmann-La Roche and Lonza founded the Basel Foundation for Developing Countries. The Basel Foundation, for example, supported the field laboratory of the Swiss Tropical Institute (now known as the Ifakara Health Institute) located in Ifakara, which still works closely with the Novartis Foundation.

Today, the Novartis Foundation focuses its work on the fight against leprosy and malaria, as well as on access to healthcare projects. The foundation acts as facilitator between the private sector, the state and civil society.

Projects

The Novartis Foundation supports access to healthcare in sub-Saharan Africa and on the Indian subcontinent. The aim is to improve access to primary healthcare and to strengthen the local healthcare systems.

The foundation fosters health policy among the private sector, non-governmental organizations, research institutions and state organizations. The foundation organizes an international symposium in Basel every year. [1] [2]

Other organisations called 'Novartis Foundation'

The Novartis Foundation was a scientific and educational charity, formed in 1949 by the Swiss company Ciba, now Novartis, and dissolved in 2008. It was the direct successor to the Ciba Foundation, and the changed name (Novartis Foundation) reflected the new name of Ciba, after merging with Sandoz. The Foundation was the brainchild of Robert Käppeli, managing director (and later president) of Ciba. The purpose of the institution was to promote collaboration in the medical sciences by the organisation of symposia which would allow experts of different fields to share ideas. Symposia took place both at their London premises and also in locations across the globe. Later these discussions were written up by in-house editors and published by John Wiley & Sons, with whom the foundation had a long-standing relationship.

Novartis, though it provided financial support for the foundation, was not (in later years) represented on the board of trustees and occupied only a minority of seats on the executive council. The company withdrew their financial support from the foundation in February 2008. The trustees chose to undergo a merger with the Academy of Medical Sciences, which occurred on 31 July 2008 prior to the dissolution of the foundation later that year [3] The foundation had its headquarters at 41 Portland Place in central London, UK. The headquarters was refurbished and reopened by the Academy of Medical Sciences in 2010. [4]

Related Research Articles

<span class="mw-page-title-main">Novartis</span> Swiss multinational pharmaceutical corporation

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.

<span class="mw-page-title-main">Healthcare industry</span> Economic sector focused on health

The healthcare industry is an aggregation and integration of sectors within the economic system that provides goods and services to treat patients with curative, preventive, rehabilitative, and palliative care. It encompasses the creation and commercialization of products and services conducive to the preservation and restoration of well-being. The contemporary healthcare sector comprises three fundamental facets, namely services, products, and finance. It can be further subdivided into numerous sectors and categories and relies on interdisciplinary teams of highly skilled professionals and paraprofessionals to address the healthcare requirements of both individuals and communities.

Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland. Sandoz is one of the leading global generics businesses.

<span class="mw-page-title-main">Ciba Specialty Chemicals</span> Swiss chemical company

Ciba was a chemical company based in and near Basel, Switzerland. "Ciba" stood for "Chemische Industrie Basel" and was formed when the non-pharmaceuticals elements of Novartis were spun out in 1997, following the merger in the previous year of Ciba-Geigy and Sandoz that created Novartis.

<span class="mw-page-title-main">Ifakara</span> Town in Morogoro Region, Tanzania

Ifakara is a town in the Kilombero District, Morogoro Region, south central Tanzania. It is the headquarters of the Kilombero District administration and the main trading centre for Kilombero and Ulanga districts. The town is located near the Tanzania-Zambia Railway (TAZARA) line, at the edge of the Kilombero Valley, a vast swampland flooded by the mighty Kilombero River.

The European and Developing Countries Clinical Trials Partnership (EDCTP) is a partnership between the European Union (EU), Norway, Switzerland and developing countries and other donors, as well as the pharmaceutical industry, to enable clinical trials and the development of new medicines and vaccines against HIV/AIDS, tuberculosis, and malaria. The need for global action against these diseases in order to promote poverty reduction has been recognised by the United Nations, the G8, and the African Union, and the program envisioned the provision of €600 million for the period 2003–2007 in order to translate medical research results into clinical applications relevant to the needs of developing countries.

<span class="mw-page-title-main">Clariant</span> Swiss specialty chemicals company

Clariant AG is a Swiss multinational speciality chemical company, formed in 1995 as a spin-off from Sandoz. Headquartered in Muttenz, Switzerland, the public company encompasses 74 subsidiaries in 36 countries (2022). Major manufacturing sites are located in Europe, North America, South America, China, and India. In 2022, sales from continuing operations were 5.198 billion CHF.

<span class="mw-page-title-main">Daniel Vasella</span>

Daniel Lucius Vasella is a Swiss medical doctor, author, and executive who was CEO and chairman of the Swiss pharmaceutical company Novartis AG, the world's fifth largest drug company. During his tenure Novartis shares fell 10%, compared to the industry average. In February 2013 Vasella was awarded close to $78 million in a "golden handshake"

<span class="mw-page-title-main">Frank H. Netter</span> American surgeon (1906–1991)

Frank Henry Netter was an American surgeon and medical illustrator. The first edition of his Atlas of Human Anatomy — his "personal Sistine Chapel" — was published in 1989; he was a fellow of the New York Academy of Medicine where he was first published in 1957.

The Crohn's & Colitis Foundation (CCF) is a non-profit organization in the US that works to fund research to find cures for Crohn's disease and ulcerative colitis, as well as ways to improve the quality of life of people affected by these digestive diseases. Founded by Shelby Modell and Irwin M. Rosenthal,and formerly known as The National Foundation for Ileitis and Colitis, and The Crohn's and Colitis Foundation of America.It was incorporated on December 17, 1965.CCF has more than 50,000 members, served by the national headquarters, as well as over 40 chapters nationwide.

Network for Excellence in Health Innovation (NEHI), formerly New England Healthcare Institute is a member-based, non-partisan research and policy organization.

<span class="mw-page-title-main">Klaus M. Leisinger</span> Swiss social scientist and economist (born 1947)

Klaus M. Leisinger is a social scientist and economist. He is founder and president of the Global Values Alliance in Basel. Until 2012 he was managing director and chairman of the Board of Trustees of the Novartis Foundation in Basel, Switzerland.

<span class="mw-page-title-main">Dimagi</span>

Dimagi, Inc. is a for-profit social enterprise based in Cambridge, Massachusetts, USA, that delivers open-source software technology suitable for low-resource settings and underserved communities. The company designs clinical interfaces, health information systems, and mobile technologies to perform patient-level disease management, clinical decision support, and health system monitoring. It also provides implementation services on open-source information and technology. Dimagi became a certified B corporation in 2008 and an incorporated benefit corporation in 2012. Dimagi has additional offices in Washington DC, New Delhi, India and Cape Town, South Africa.

<span class="mw-page-title-main">Pharmaceutical industry in Switzerland</span> Overview of the pharmaceutical industry in Switzerland

The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people. It contributes 5.7% of the gross domestic product of Switzerland and 30% of the country's exports. In 2017 about 30% of Swiss exports were chemical products. In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion.

The Sandoz Family Foundation, created in 1964, is a private Swiss foundation.

<span class="mw-page-title-main">Healthcare in Somalia</span>

Healthcare in Somalia is largely in the private sector. It is regulated by the Ministry of Health of the Federal Government of Somalia. In March 2013, the central authorities launched the Health Sector Strategic Plans (HSSPs), a new national health system that aims to provide universal basic healthcare to all citizens by 2016. Somalia has the highest prevalence of mental illness in the world, according to the World Health organization. Some polls have ranked Somalis as the happiest people in Sub-Saharan Africa.

<span class="mw-page-title-main">PharmAccess Foundation</span> Non-profit organization

PharmAccess Foundation is a part of the PharmAccess Group. PharmAccess is an international non-profit organization with a digital agenda dedicated to connecting more people in sub-Saharan Africa to better healthcare. By making use of public-private partnerships, they leverage donor contributions, which they believe will pave the way for private investments thereby contributing to healthier populations and social and economic development. Currently, PharmAccess employs a multidisciplinary team of professionals in Tanzania, Kenya, Nigeria, Ghana and the Netherlands.

<span class="mw-page-title-main">Rudolf Geigy</span> Swiss zoologist

Rudolf Geigy was a Swiss biologist and a professor of embryology and genetics at the University of Basel. He established the Swiss Tropical and Public Health Institute and studied tropical diseases.

Jörg Reinhardt has been Chairman of the Board of Directors of the Swiss pharmaceutical group Novartis AG since 2013. Since 2017, he has also been a member of the Board of Directors of the Swiss reinsurance group Swiss Re.

References

  1. Website Novartis Foundation: Projects
  2. Annual Report 2008
  3. "novartisfound.org.uk". novartisfound.org.uk. Retrieved 2014-02-19.
  4. "novartisfound.org.uk". novartisfound.org.uk. Retrieved 2014-02-19.